M. Cumberbatch

发表

Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5‐HT1B/1D agonist

R. Hargreaves, R. Hargreaves, G. Mason, 1999, British journal of pharmacology.

Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats

D. Cook, R. Hargreaves, R. Hargreaves, 2001, British journal of pharmacology.

The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

S. Tye, R. Hargreaves, F. D. Tattersall, 2000, Neuropharmacology.

The Pharmacology and Mechanisms of Action of Rizatriptan

R. Hargreaves, G. Seabrook, M. Beer, 2000 .

Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats

S. Boyce, R. Hill, N. Rupniak, 1998, Neuropharmacology.

Exposure of rat spinal neurones to NMDA, AMPA and kainate produces only short-term enhancements of responses to noxious and non-noxious stimuli

P. Headley, J. F. Herrero, M. Cumberbatch, 1994, Neuroscience Letters.

Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord

B. Chizh, P. Birch, M. Cumberbatch, 1995, British journal of pharmacology.

AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission.

P. Headley, B. Chizh, M. Cumberbatch, 1994, Neuroreport.

Spinal nociceptive processing: NMDA receptors and modulation by neuropeptides

P. Headley, B. Chizh, M. Cumberbatch, 2002 .

Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord

B. Chizh, M. Cumberbatch, P. MaxHeadley, 1995, British journal of pharmacology.

The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.

R. Hargreaves, R. Hill, M. Cumberbatch, 1998, European journal of pharmacology.

Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity

M. Rigby, C. Swain, K. Maubach, 2002, The Journal of Neuroscience.

A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord

P. Headley, B. Chizh, M. Cumberbatch, 1994, British journal of pharmacology.

Rizatriptan has central antinociceptive effects against durally evoked responses.

R. Hargreaves, R. Hill, M. Cumberbatch, 1997, European journal of pharmacology.

Possible Antimigraine Mechanisms of Action of the 5HT1F Receptor Agonist LY334370

S. Boyce, R. Hargreaves, L. Edvinsson, 1999, Cephalalgia : an international journal of headache.

Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus

K. Maubach, G. Seabrook, G. Chicchi, 2002, Neuroscience.

Antagonism of synaptic potentials in ventral horn neurones by 6‐cyano‐7‐nitroquinoxaline‐2,3‐dione: a study in the rat spinal cord in vitro

J. Lopez-Garcia, A. King, M. Cumberbatch, 1992, British journal of pharmacology.

Stimulus intensity, cell excitation and the N-methyl-d-aspartate receptor component of sensory responses in the rat spinal cord in vivo

P. Headley, B. Chizh, J. F. Herrero, 1997, Neuroscience.

Studies of synaptic transmission in vivo: indirect versus direct effects of (RS)-α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid/kainate antagonists on rat spinal sensory responses

P. Headley, J. F. Herrero, M. Cumberbatch, 1996, Neuroscience Letters.

The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbits.

G. Mason, R. Hill, N. Rupniak, 2002, Canadian journal of physiology and pharmacology.

A comparison ofintravenous NBQX andGYKI53655 as AMPA antagonists intheratspinal cord

B. Chizh, M. Cumberbatch, 1994 .